{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T08:53:56Z","timestamp":1770022436526,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jcyt.2022.03.003","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T17:13:23Z","timestamp":1649351603000},"page":"879-883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rapid potency assessment of autologous peripheral blood stem cells by intracellular flow cytometry: the PBSC-IL-3-pSTAT5 assay"],"prefix":"10.1016","volume":"24","author":[{"given":"Carl","family":"Simard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0082-0944","authenticated-orcid":false,"given":"Nicolas","family":"Pineault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8645-6230","authenticated-orcid":false,"given":"Patrick","family":"Tr\u00e9panier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jcyt.2022.03.003_bib0001","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bbmt.2015.07.032","article-title":"Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation","volume":"21","author":"Majhail","year":"2015","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.jcyt.2022.03.003_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.03.015","article-title":"The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic","author":"Hsu","year":"2021","journal-title":"Transplantation and Cellular Therapy"},{"issue":"2","key":"10.1016\/j.jcyt.2022.03.003_bib0003","doi-asserted-by":"crossref","DOI":"10.4172\/2157-7013.S13-001","article-title":"Potency, Proliferation and Engraftment Potential of Stem Cell Therapeutics: The Relationship between Potency and Clinical Outcome for Hematopoietic Stem Cell Products","volume":"4","author":"N Rich","year":"2013","journal-title":"Journal of Cell Science & Therapy"},{"issue":"9","key":"10.1016\/j.jcyt.2022.03.003_bib0004","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/sj.bmt.1704926","article-title":"Association of post-thaw viable CD34+ cells and CFU-GM with time to hematopoietic engraftment","volume":"35","author":"Yang","year":"2005","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"10.1016\/j.jcyt.2022.03.003_bib0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jcyt.2012.11.013","article-title":"Current practices and prospects for standardization of the hematopoietic colony-forming unit assay: a report by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative","volume":"15","author":"Pamphilon","year":"2013","journal-title":"Cytotherapy"},{"issue":"19","key":"10.1016\/j.jcyt.2022.03.003_bib0006","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1182\/blood-2015-08-666990","article-title":"Development and validation of a rapid, aldehyde dehydrogenase bright\u2013based cord blood potency assay","volume":"127","author":"Shoulars","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jcyt.2022.03.003_bib0007","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12967-015-0434-z","article-title":"Detecting primitive hematopoietic stem cells in total nucleated and mononuclear cell fractions from umbilical cord blood segments and units","volume":"13","author":"Patterson","year":"2015","journal-title":"Journal of Translational Medicine"},{"issue":"3","key":"10.1016\/j.jcyt.2022.03.003_bib0008","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1537-2995.2011.03305.x","article-title":"Flow cytometry assessment of apoptotic CD34+ cells by annexin V labeling may improve prediction of cord blood potency for engraftment","volume":"52","author":"Duggleby","year":"2012","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.jcyt.2022.03.003_bib0009","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1111\/trf.15220","article-title":"An objective flow cytometry method to rapidly determine cord blood potency in cryopreserved units","volume":"59","author":"Simard","year":"2019","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.jcyt.2022.03.003_bib0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0889-8588(18)30540-9","article-title":"Interleukin-3: Molecular Biology and Biologic Activities","volume":"3","author":"Yang","year":"1989","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"12","key":"10.1016\/j.jcyt.2022.03.003_bib0011","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1182\/blood-2002-05-1602","article-title":"Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells","volume":"100","author":"Bradley","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2022.03.003_bib0012","unstructured":"The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry. Journal of Hematotherapy."},{"issue":"6","key":"10.1016\/j.jcyt.2022.03.003_bib0013","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jca.20220","article-title":"Postthaw clotting of peripheral blood stem cell products due to insufficient anticoagulant","volume":"24","author":"Reich-Slotky","year":"2009","journal-title":"Journal of Clinical Apheresis"},{"issue":"9","key":"10.1016\/j.jcyt.2022.03.003_bib0014","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","article-title":"Receiver Operating Characteristic Curve in Diagnostic Test Assessment","volume":"5","author":"Mandrekar","year":"2010","journal-title":"Journal of Thoracic Oncology"},{"issue":"7","key":"10.1016\/j.jcyt.2022.03.003_bib0015","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.bbmt.2020.04.001","article-title":"Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis","volume":"26","author":"Hamadani","year":"2020","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.jcyt.2022.03.003_bib0016","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2021005139","article-title":"Impact of Cryopreservation and Transit Times of Allogeneic Grafts on Hematopoietic and Immune Reconstitution","author":"Maurer","year":"2021","journal-title":"Blood Advances"},{"issue":"10","key":"10.1016\/j.jcyt.2022.03.003_bib0017","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.bbmt.2007.07.003","article-title":"Similar Outcomes of Cryopreserved Allogeneic Peripheral Stem Cell Transplants (PBSCT) Compared to Fresh Allografts","volume":"13","author":"Kim","year":"2007","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.jcyt.2022.03.003_bib0018","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/s41409-021-01367-x","article-title":"Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?","volume":"56(10)","author":"Fernandez-Sojo","year":"2021","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.jcyt.2022.03.003_bib0019","doi-asserted-by":"crossref","first-page":"215.e1","DOI":"10.1016\/j.jtct.2022.01.010","article-title":"Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report","volume":"28(4)","author":"Bankova","year":"2022","journal-title":"Transplantation and Cellular Therapy"},{"issue":"6","key":"10.1016\/j.jcyt.2022.03.003_bib0020","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/bjh.14160","article-title":"Post-thaw viability of cryopreserved peripheral blood stem cells (PBSC) does not guarantee functional activity: important implications for quality assurance of stem cell transplant programmes","volume":"174","author":"Morgenstern","year":"2016","journal-title":"British Journal of Haematology"},{"issue":"1","key":"10.1016\/j.jcyt.2022.03.003_bib0021","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12967-021-02810-9","article-title":"Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site","volume":"19","author":"Wiercinska","year":"2021","journal-title":"Journal of Translational Medicine"},{"issue":"16","key":"10.1016\/j.jcyt.2022.03.003_bib0022","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1182\/blood.2021011719","article-title":"Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study","volume":"138","author":"Horwitz","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2022.03.003_bib0023","doi-asserted-by":"crossref","DOI":"10.1111\/ejh.13504","article-title":"Single UM171-expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors","author":"Claveau","year":"2020","journal-title":"European Journal of Haematology"},{"issue":"7","key":"10.1016\/j.jcyt.2022.03.003_bib0024","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3109\/14653249.2011.571249","article-title":"Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord blood","volume":"13","author":"Spellman","year":"2011","journal-title":"Cytotherapy"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324922000767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324922000767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:47:25Z","timestamp":1761443245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324922000767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1465324922000767"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2022.03.003","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid potency assessment of autologous peripheral blood stem cells by intracellular flow cytometry: the PBSC-IL-3-pSTAT5 assay","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2022.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}